Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MGC018
MGC018
Macrogenics takes another shot at a novel immune checkpoint
EP Vantage
Fri, 04/23/21 - 11:16 am
Macrogenics
MGC018
antibody-drug conjugate
Macrogenics takes another shot at a novel immune checkpoint
EP Vantage
Thu, 04/22/21 - 10:49 am
Macrogenics
MGC018
orlotamab
enoblituzumab
prostate cancer
metastatic castration-resistant prostate cancer
